Boris Johnson and Patrick Valance - Downing Street Daily Press Briefing on Coronavirus

Boris Johnson and Patrick Valance - Downing Street Daily Press Briefing on Coronavirus

Assessment

Interactive Video

Social Studies, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses the current restrictions on holiday bookings due to COVID-19, with a focus on the new variant found in Bristol. It highlights the importance of monitoring data and setting a roadmap for easing restrictions. The discussion also covers the transmissibility and severity of virus variants, the effectiveness of vaccines, and the critical need for vaccination to control the spread of the virus. Emphasis is placed on reducing case numbers to prevent further mutations.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the current legal status of booking holidays according to the transcript?

It is encouraged to boost the economy.

It is currently illegal.

It is allowed with certain restrictions.

It is only allowed for essential travel.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a potential concern regarding the new variant found in Bristol?

It is resistant to all known vaccines.

It could be more transmissible and severe.

It has no significant differences from the original virus.

It may be less transmissible than other variants.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the primary strategy mentioned to combat the spread of COVID-19 variants?

Increasing travel restrictions.

Developing new vaccines.

Implementing stricter lockdowns.

Getting vaccinated and reducing case numbers.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which variant is mentioned as having a similar change to the Bristol variant?

The Kent variant.

The Indian variant.

The South African variant.

The Brazilian variant.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is it important to keep testing the vaccine effects against new variants?

To develop new vaccines quickly.

To ensure vaccines are still effective.

To reduce the cost of vaccines.

To increase vaccine production.